Bremelanotide
Bremelanotide (pronounced breh-meh-LAN-oh-tide) is a type of peptide that is used as a treatment for sexual dysfunction in both men and women. It is marketed under the brand name Vyleesi in the United States.
Etymology
The term "Bremelanotide" is derived from the words "bremelanotropin", which is a synthetic peptide, and "tide", a common suffix used in the names of peptides.
Usage
Bremelanotide is used to treat Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women. It is also being studied for its potential use in treating erectile dysfunction in men. The drug works by activating the melanocortin receptors in the brain, which are involved in sexual arousal and appetite.
Administration
Bremelanotide is administered via a subcutaneous injection, typically in the abdomen or thigh. It is recommended to be used 45 minutes before sexual activity.
Side Effects
Common side effects of Bremelanotide include nausea, flushing, and headache. In rare cases, it can cause more serious side effects such as high blood pressure and darkening of the skin.
Related Terms
- Peptide
- Sexual dysfunction
- Hypoactive Sexual Desire Disorder
- Erectile dysfunction
- Melanocortin receptors
External links
- Medical encyclopedia article on Bremelanotide
- Wikipedia's article - Bremelanotide
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski